The efficacy of boosters against COVID-19 is likely to decline over the next few months and people may need another shot in the fall of 2022, Moderna Inc chief executive officer Stephane Bancel said at a Goldman Sachs-organized health care conference on Thursday.
Bancel said the company is working on a vaccine candidate tailored to the Omicron variant of the coronavirus, but is unlikely to be available in the next two months.
![](https://projectprotech.ca/wp-content/uploads/2022/01/image-51-727x548.png)
“I still believe we’re going to need boosters in the fall of ‘22 and forward,” Bancel said.
His comments on needing a fourth shot come on the back of Israeli Prime Minister Naftali Bennett citing a study on Tuesday that a fourth dose of COVID-19 vaccine boosts antibodies five-fold a week after the shot is administered.
Moderna, which benefits by repeat inoculations, during its third quarter earnings results said commercial booster market sales could be up to $2-billion in the United States in 2022.
Article From: Globe and Mail
Author: REUTERS